134 related articles for article (PubMed ID: 8306321)
21. In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™).
Canta A; Chiorazzi A; Carozzi V; Meregalli C; Oggioni N; Sala B; Crippa L; Avezza F; Forestieri D; Rotella G; Zucchetti M; Cavaletti G
Cancer Chemother Pharmacol; 2011 Oct; 68(4):1001-8. PubMed ID: 21327681
[TBL] [Abstract][Full Text] [Related]
22. Transplacental passage of Pt after treatment with the new triamine complex cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N4]-chloride platinum (II) monohydrochloride monohydrate.
Ognio E; Chiavarina B; Caviglioli G; Lapide M; Viale M
Arch Toxicol; 2004 Oct; 78(10):584-8. PubMed ID: 15150682
[TBL] [Abstract][Full Text] [Related]
23. The effect of curcumin on oxaliplatin and cisplatin neurotoxicity in rats: some behavioral, biochemical, and histopathological studies.
Al Moundhri MS; Al-Salam S; Al Mahrouqee A; Beegam S; Ali BH
J Med Toxicol; 2013 Mar; 9(1):25-33. PubMed ID: 22648527
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of side effects of platinum complexes (CDDP, CBDCA, CHIP) on rat bone marrow.
Prajda N; Kralovánszky J; Gal F; Kiss F; Kerpel-Fronius S
In Vivo; 1989; 3(4):267-70. PubMed ID: 2519864
[TBL] [Abstract][Full Text] [Related]
25. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR
Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318
[TBL] [Abstract][Full Text] [Related]
26. Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats.
Tredici G; Braga M; Nicolini G; Miloso M; Marmiroli P; Schenone A; Nobbio L; Frattola L; Cavaletti G
Exp Neurol; 1999 Oct; 159(2):551-8. PubMed ID: 10506527
[TBL] [Abstract][Full Text] [Related]
27. Neuronal expression of copper transporter 1 in rat dorsal root ganglia: association with platinum neurotoxicity.
Liu JJ; Jamieson SM; Subramaniam J; Ip V; Jong NN; Mercer JF; McKeage MJ
Cancer Chemother Pharmacol; 2009 Sep; 64(4):847-56. PubMed ID: 19466412
[TBL] [Abstract][Full Text] [Related]
28. Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats.
Hanada K; Asano K; Nishimura T; Chimata T; Matsuo Y; Tsuchiya M; Ogata H
J Pharm Pharmacol; 2008 Mar; 60(3):317-22. PubMed ID: 18284811
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxicity of tetraplatin and cisplatin for human and rodent cell lines cultured as monolayers and multicellular spheroids.
Bhuyan BK; Folz SJ; DeZwaan J; Northcott SE; Alberts DS; Garcia D; Wallace TL; Li LH
Cancer Commun; 1991 Feb; 3(2):53-9. PubMed ID: 1995028
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotective interactions in rats between paclitaxel and cisplatin.
McKeage MJ; Haddad GG; Ding L; Galettis P; Screnci D; Zhuang L; Baguley BC
Oncol Res; 1999; 11(6):287-93. PubMed ID: 10691031
[TBL] [Abstract][Full Text] [Related]
31. Low-dose glutathione administration in the prevention of cisplatin-induced peripheral neuropathy in rats.
Tredici G; Cavaletti G; Petruccioli MG; Fabbrica D; Tedeschi M; Venturino P
Neurotoxicology; 1994; 15(3):701-4. PubMed ID: 7854609
[TBL] [Abstract][Full Text] [Related]
32. Sex-related differences in cisplatin-induced neuropathy in rats.
Wongtawatchai T; Agthong S; Kaewsema A; Chentanez V
J Med Assoc Thai; 2009 Nov; 92(11):1485-91. PubMed ID: 19938741
[TBL] [Abstract][Full Text] [Related]
33. Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding.
Ta LE; Espeset L; Podratz J; Windebank AJ
Neurotoxicology; 2006 Dec; 27(6):992-1002. PubMed ID: 16797073
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
Bianchi R; Brines M; Lauria G; Savino C; Gilardini A; Nicolini G; Rodriguez-Menendez V; Oggioni N; Canta A; Penza P; Lombardi R; Minoia C; Ronchi A; Cerami A; Ghezzi P; Cavaletti G
Clin Cancer Res; 2006 Apr; 12(8):2607-12. PubMed ID: 16638873
[TBL] [Abstract][Full Text] [Related]
35. Comparison of reproductive toxicity caused by cisplatin and novel platinum-N-heterocyclic carbene complex in male rats.
Ciftci O; Beytur A; Cakir O; Gurbuz N; Vardi N
Basic Clin Pharmacol Toxicol; 2011 Nov; 109(5):328-33. PubMed ID: 21624060
[TBL] [Abstract][Full Text] [Related]
36. Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer.
Sugiyama T; Kumagai S; Nishida T; Ushijima K; Matsuo T; Yakushiji M; Hyon SH; Ikada Y
Anticancer Res; 1998; 18(4B):2837-42. PubMed ID: 9713471
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo antitumour effects of novel, orally active bile acid-conjugated platinum complexes on rat hepatoma.
Barbara C; Orlandi P; Bocci G; Fioravanti A; Di Paolo A; Natale G; Del Tacca M; Danesi R
Eur J Pharmacol; 2006 Nov; 549(1-3):27-34. PubMed ID: 16978599
[TBL] [Abstract][Full Text] [Related]
38. Novel platinum-N-heterocyclic carbene complex is more cardiotoxic than cis-platin in rats.
Ciftci O; Ozdemir I; Vardi N; Gurbuz N
Hum Exp Toxicol; 2011 Sep; 30(9):1342-9. PubMed ID: 21075807
[TBL] [Abstract][Full Text] [Related]
39. In vitro toxicological evaluation of a dinuclear platinum(II) complex with acetate ligands.
Momekov G; Ferdinandov D; Bakalova A; Zaharieva M; Konstantinov S; Karaivanova M
Arch Toxicol; 2006 Sep; 80(9):555-60. PubMed ID: 16485120
[TBL] [Abstract][Full Text] [Related]
40. Embryo-lethal and teratogenic effect of the new platinum compound DPR in pregnant mice.
Ognio E; Lapide M; Ottone M; Mandys V; Peterka M; Parodi B; Viale M
Arch Toxicol; 2003 Oct; 77(10):584-90. PubMed ID: 14574446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
